Trials of vision-improving substances are showing good results, though so far only two have been authorized for use in the United States.
Some people say their short-sightedness gets better as they get older – but can this be true? We explain what really happens ...
The Federal Ministry of Health and Social Welfare has reiterated its commitment to preventing avoidable blindness and ...
Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Presbyopia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through ...
Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. LENZ Therapeutics ( (LENZ)) just unveiled ...
As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...
VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia for up to 10 hours, a condition impacting approximately 128 million adults in the United ...
Credit: Lenz Therapeutics. Vizz eye drops contain a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, resulting in a pinhole effect that extends focus depth to ...
As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback